Zymeworks Inc. Share Price Toronto S.E.
Equities
ZYME
CA98985W1023
Biotechnology & Medical Research
Sales 2024 * | 95.49M 130M 7.52B | Sales 2025 * | 107M 146M 8.43B | Capitalization | 650M 885M 51.18B |
---|---|---|---|---|---|
Net income 2024 * | -87M -118M -6.85B | Net income 2025 * | -90M -122M -7.09B | EV / Sales 2024 * | 6.02 x |
Net cash position 2024 * | 75.44M 103M 5.94B | Net cash position 2025 * | 75.78M 103M 5.97B | EV / Sales 2025 * | 5.37 x |
P/E ratio 2024 * |
-7.81
x | P/E ratio 2025 * |
-6.79
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.25% |
Latest transcript on Zymeworks Inc.
1st Jan change | Capi. | |
---|---|---|
+9.42% | 115B | |
+11.84% | 106B | |
-14.15% | 21.84B | |
-1.05% | 21.96B | |
-5.29% | 19.21B | |
-38.29% | 17.71B | |
-4.16% | 18.08B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |